Format

Send to:

Choose Destination
See comment in PubMed Commons below
Leuk Lymphoma. 1994 Jun;14(1-2):137-9.

Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.

Author information

  • 1Division of Internal Medicine and Hematology, Mayo Clinic, Rochester, Minnesota 55905.

Abstract

This report describes two cases of T-cell chronic lymphocytic leukemia (T-CLL) treated with purine nucleoside analogues. One patient had CD8+, CD3+ large granular lymphocytosis (LGL) producing transfusion-dependent anemia and was refractory to chemotherapy. Treatment with four cycles of fludarabine produced a clinical complete remission and a molecular genetic partial remission that has been durable for > 15 months. The other patient had CD4+ T-prolymphocytic leukemia and was unresponsive to both fludarabine and 2-chlorodeoxyadenosine. Further trials of these agents are warranted in T-CLL, especially the LGL variant.

PMID:
7920220
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk